Akèy › Degeneresans makile › Massachusetts
Etid klinik pou Degeneresans makile nan Massachusetts
14 etid pou Degeneresans makile ap chèche patisipan nan sit nan Massachusetts.
Vil nan Massachusetts
Tèks ofisyèl etid la (Anglè)
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Ophthalmic Consultants of Boston, Boston
Ap rekriteFaz 2/3
Laj 60 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT06635148A Study in Adults With Geographic Atrophy
- Ophthalmic Consultants of Boston, Waltham
Ap rekriteFaz 2
Laj 60 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07606365A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Massachusetts Eye And Ear Infirmary, Boston
- Opthalmic Consultants of Boston, Boston
- New England Retina Consultants, PC, Springfield
- ak 2 plis
Ap rekriteFaz 3
Laj 50 a 85 · Tout sèks · Mizajou Sep 18, 2026 · NCT06541704Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Retina Research Institute at New England Retina Consultants, Springfield
Ap rekriteFaz 2
Laj 55 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06659445A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- Ophthalmic Consultants of Boston, Boston
Ap rekriteFaz 1
Laj 50 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT03178149A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
- Ophthalmic Consultants of Boston, Boston
Ap rekriteEtid obsèvasyon
Laj 50 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT063466004D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
- Ophthalmic Consultants of Boston & Boston Eye Surgery and Laser Center, Boston
Ap rekriteFaz 1/2
Laj 50 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT05197270A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
- Retina Research Institute at New England Retina Consultants, PC, Springfield
Ap rekriteFaz 2/3
Laj 50 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT07496567Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
- Ophthalmic Consultants of Boston, East Weymouth
Ap rekriteFaz 1
Laj 50 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT07230834The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, DR and Glaucoma
- MCPHS 10 Lincoln Square, Worcester
Ap rekriteFaz 1 bonèVolontè an sante akeyi
Laj 50 a 100 · Tout sèks · Mizajou May 12, 2026 · NCT06593405Vision Rehabilitation Training With Multimodal Feedback in Central Vision Loss
- New England College of Optometry, Boston
Ap rekrite
Laj 14 ak plis · Tout sèks · Mizajou May 11, 2026 · NCT07577219Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- New England Retina Consultants, Springfield
Ap rekriteFaz 3
Laj 50 ak plis · Tout sèks · Mizajou Apr 16, 2026 · NCT07064759Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD
- Massachusetts Eye and Ear Infirmary, Boston
Ap rekriteFaz 2
Laj 50 a 85 · Tout sèks · Mizajou Jan 26, 2026 · NCT04735263Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
- Tallman Eye Associates, Lawrence
Ap rekrite
Laj 65 ak plis · Tout sèks · Mizajou Dec 3, 2024 · NCT05438732Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.